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Abstract Membrane cholesterol is essential to the activity of
at least two structurally unrelated families of bacterial pore-
forming toxins, represented by streptolysin O (SLO) and Vibrio
cholerae cytolysin (VCC), respectively. Here, we report that
SLO and VCC di¡er sharply in their interaction with liposome
membranes containing enantiomeric cholesterol (ent-cholester-
ol). VCC had very low activity with ent-cholesterol, which is
in line with a stereospeci¢c mode of interaction of this toxin
with cholesterol. In contrast, SLO was only slightly less active
with ent-cholesterol than with cholesterol, suggesting a rather
limited degree of structural speci¢city in the toxin^cholesterol
interaction.
( 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
Key words: Streptolysin O; Cholesterol-binding cytolysins;
Vibrio cholerae cytolysin; Protein^cholesterol interaction;
Enantiomeric cholesterol
1. Introduction
Bacterial cytolysins or pore-forming toxins must possess
some degree of speci¢city for animal as opposed to bacterial
cell membranes. With two distinct families of oligomerizing,
pore-forming toxins, this speci¢city is mediated by membrane
cholesterol. The sterol requirement of streptolysin O (SLO)
has long been recognized, and SLO and the toxins homolo-
gous to it are frequently referred to as the ‘cholesterol-binding
cytolysins’ [1]. The latter name is actually at odds with the
following experimental observations:
1. With at least one member of this class of toxins (listerio-
lysin), binding (though not oligomerization) has been ob-
served with liposomes not containing cholesterol [2].
2. Modi¢cation of the single cysteine residue shared by most
toxins abrogates binding to membranes but not to choles-
terol [3].
Binding to cholesterol and binding to the membrane, re-
spectively, therefore do not seem to be equivalent. The crystal
structure of one of the ‘cholesterol-binding cytolysins’ (per-
fringolysin O, secreted by Clostridium perfringens) has been
determined [4]. It has since become clear that membrane bind-
ing of the monomer is mediated by the C-terminal domain 4
of the toxin molecule [5], apparently by a con¢ned, trypto-
phan-rich motif around the single cysteine residue, which re-
mains the only membrane-inserted part of that domain even
after oligomerization and pore formation [6]. It is, however,
not possible at present to assign individual amino acid resi-
dues that are directly involved in the interaction with the
sterol.
More recently, the hemolytic cytolysin secreted by Vibrio
cholerae El-Tor has been found to also require cholesterol
for membrane permeabilization [7]. This toxin is not detect-
ably related to the SLO family at the level of amino acid
sequence, and known close homologues so far are restricted
to the genus Vibrio. V. cholerae cytolysin (VCC) also di¡ers
considerably from SLO in pore size, which is V1.5 nm in
diameter [8] compared with up to 30 nm [9] for SLO. While
a structural model of VCC has recently been reported [10],
experimental data to assign residues involved in membrane
interaction is still wanting.
In the present study, we have examined the speci¢city of
SLO and of VCC for cholesterol using enantiomeric choles-
terol (ent-cholesterol) as a probe. Cholesterol and ent-choles-
terol have mirror image shapes, but identical physical proper-
ties; ent-cholesterol is therefore very suitable as a probe of
stereospeci¢city in the interaction between proteins and cho-
lesterol.
2. Materials and methods
SLO was recombinantly expressed in Escherichia coli and puri¢ed
by successive a⁄nity and hydroxylapatite chromatography [11]. VCC
was puri¢ed from culture supernatants of V. cholerae by isoelectric
focusing [12]. The synthesis of ent-cholesterol has been described else-
where [13,14]. Egg yolk phosphatidylcholine and phosphatidylglycerol
were obtained from Avanti Polar Lipids (Alabaster, AL, USA). Ga-
lactosylceramide (from bovine brain), cholesterol, 7K- and 19-hy-
droxycholesterol, cholesterol-3L-acetate, and 3L-thiocholesterol were
obtained from Sigma. The commercially obtained lipids were used
without further puri¢cation.
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2.1. Liposome permeabilization experiments
Liposomes containing trapped calcein were prepared from egg yolk
phosphatidylcholine (45% by mol), phosphatidylglycerol (2%), galac-
tosylceramide (20%), and the sterol in question (33%) by extrusion
through Nuclepore polycarbonate membranes [15,16]. For controls
without any sterols, the content of phosphatidylcholine was increased
to 58%, whereas the fractional content of the other components re-
mained unchanged. Calcein release assays were performed using two-
fold serial dilutions of VCC or SLO, to which constant amounts of
the liposomes in question were added (¢nal concentration of total
lipid: 0.1 mg/ml). The percentage of calcein released was determined
£uorometrically after incubation at 37‡C for 10 min. Additional de-
tails can be found elsewhere [16].
3. Activity of VCC and SLO on membranes containing
cholesterol and ent-cholesterol
Fig. 1A,B shows the permeabilization of liposomal model
membranes containing cholesterol or ent-cholesterol (33% by
mol) in a background of PC and galactosylceramide. Both
VCC and SLO e⁄ciently permeabilize membranes with cho-
lesterol. If ent-cholesterol replaces cholesterol, VCC shows
very limited permeabilization, only marginally exceeding that
observed with control vesicles not containing any sterol at all
(Fig. 1A). This ¢nding is in accordance with the concept of a
speci¢c toxin^sterol interaction. SLO, too, is inactive with
vesicles lacking cholesterol ; however, in contrast to VCC, it
displays a very considerable activity with ent-cholesterol (Fig.
1B).
4. Interaction of SLO and VCC with other cholesterol
derivatives
Fig. 1C shows the permeabilization by VCC and SLO of
liposome membranes containing two cholesterol derivatives,
7K- and 19-hydroxycholesterol. VCC shows considerable ac-
tivity with 7K-hydroxycholesterol but is virtually inactive with
the 19-hydroxysterol, as is SLO with either derivative. These
¢ndings are compatible with the assumption that both toxins
interact with cholesterol in a structurally speci¢c way, where-
by the 7K-hydroxyl group would be in an obtrusive position
with SLO but not VCC.
SLO did not induce any detectable permeabilization of
membranes containing either 3L-thiocholesterol or cholesterol
acetate. VCC was also inactive with thiocholesterol but dis-
played a low degree of activity with cholesterol acetate (data
not shown).
5. Conclusion
The collective results are compatible with a stereospeci¢c
mutual interaction of cholesterol and VCC. In contrast, there
seems to be a discrepancy in the case of SLO: The inactivity
observed with most cholesterol analogs suggests a high degree
of speci¢city; however, the opposite is favored by the fact that
SLO is active with ent-cholesterol. The latter ¢nding imposes
a rather surprising twist to the customary concept of a mu-
tually speci¢c toxin^cholesterol interaction [17,18]. If discrim-
ination between enantiomers is taken as a measure of struc-
tural speci¢city, then SLO appears to have a strikingly low
degree of speci¢city for the sterol. On the other hand, any
modi¢cation of the 3L-hydroxy group completely abrogates
the activity of SLO or its homologous toxin perfringolysin
O [19]. This suggests that the toxins’ speci¢city is largely con-
¢ned to the most surface-exposed part of the sterol molecule.
The latter conclusion is in line with recent structural data on
perfringolysin O, which indicate that, even after completion of
toxin oligomerization and pore formation, only a rather lim-
ited part of the domain that is responsible for the initial,
sterol-dependent membrane binding actually inserts into the
lipid bilayer [6].
The question then arises why both 7K- and 19-hydroxycho-
lesterol fail to support SLO activity to any detectable extent.
If these sterols were to assume the same orientation in the
membrane as cholesterol, then their respective accessory hy-
droxyl groups should be located remote from the membrane
Fig. 1. Activity of VCC and SLO on membranes containing choles-
terol, ent-cholesterol, and 7K- or 19-hydroxycholesterol. Liposomes
containing the sterol in question (33% by mol; see Section 2 for re-
sidual lipid composition) and ¢lled with calcein were incubated with
VCC or SLO at the concentrations indicated, and the extent of cal-
cein release was determined by an increase in £uorescence. A: Ac-
tivity of VCC with cholesterol and ent-cholesterol. B: Activity of
SLO with cholesterol and ent-cholesterol. C: Activity of VCC and
SLO with 7K- and 19-hydroxycholesterol.
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surface, thereby precluding their interference with the toxin^
sterol interaction. This suggests a deviant orientation of these
two sterols in the membrane. With 7K-cholesterol, a previous
study indeed suggests that both the 3L^hydroxyl group and
the 7K-hydroxyl group are in contact with the aqueous phase,
and the body of the molecule is accordingly tilted [20].
In summary, our study supports a stereospeci¢c mode of
cholesterol interaction with VCC, but not with SLO, the ‘clas-
sic’ cholesterol-binding toxin. The ¢ndings illustrate the use-
fulness of ent-cholesterol as a probe of structural speci¢city in
protein^cholesterol interaction.
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